Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 972 products on this category.

Product data	Purity	Price range	Estimated delivery
Nintedanib Impurity 29 REF: 4Z-N-066046	- - -	To inquire	Mon 10 Mar 25
Nintedanib Impurity 66 REF: 4Z-N-066084CAS: 2186-92-7	- - -	To inquire	Mon 10 Mar 25
Fulvestrant Impurity 17 REF: 4Z-F-3125	- - -	To inquire	Mon 10 Mar 25
Olaparib Impurity 16 (Dimethyl phosphite) REF: 4Z-O-032018CAS: 868-85-9	- - -	To inquire	Mon 10 Mar 25
Abiraterone Impurity 4 REF: 4Z-A-8237CAS: 2118-32-3	- - -	To inquire	Mon 10 Mar 25
(E/Z)Tamoxifen REF: 4Z-T-0121CAS: 7728-73-6	- - -	To inquire	Mon 10 Mar 25
Lenvatinib Impurity 35 REF: 4Z-L-124041	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 17 REF: 4Z-C-121020CAS: 247068-83-3	- - -	To inquire	Mon 10 Mar 25
Palbociclib Impurity 14 REF: 4Z-P-196018CAS: 51534-87-3	- - -	To inquire	Mon 10 Mar 25
Palbociclib Impurity 28 REF: 4Z-P-196032	- - -	To inquire	Mon 10 Mar 25
Bestatin Impurity 1 REF: 4Z-B-119004CAS: 62023-63-6	- - -	To inquire	Mon 10 Mar 25
N-Nitroso Olaparib Impurity 13 REF: 4Z-O-032078CAS: 2742659-74-9	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 47 REF: 4Z-C-121050CAS: 82732-07-8	- - -	To inquire	Mon 10 Mar 25
Nintedanib N-Glucuronide-2 REF: 4Z-N-066037	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 25 REF: 4Z-C-121028CAS: 2049024-37-3	- - -	To inquire	Mon 10 Mar 25
Enzalutamide Impurity 13 REF: 4Z-E-068026	- - -	To inquire	Mon 10 Mar 25
Nintedanib Impurity 55 REF: 4Z-N-066073	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 24 REF: 4Z-C-121027CAS: 2049025-49-0	- - -	To inquire	Mon 10 Mar 25
Lenvatinib Impurity 38 Chloride REF: 4Z-L-124044CAS: 6118-33-8	- - -	To inquire	Mon 10 Mar 25
Carfilzomib Impurity 57 REF: 4Z-C-121060CAS: 254888-42-1	- - -	To inquire	Mon 10 Mar 25

5mg		To inquire
10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

Cancer treatment

Nintedanib Impurity 29

Ref: 4Z-N-066046

Nintedanib Impurity 66

Ref: 4Z-N-066084

Fulvestrant Impurity 17

Ref: 4Z-F-3125

Olaparib Impurity 16 (Dimethyl phosphite)

Ref: 4Z-O-032018

Abiraterone Impurity 4

Ref: 4Z-A-8237

(E/Z)Tamoxifen

Ref: 4Z-T-0121

Lenvatinib Impurity 35

Ref: 4Z-L-124041

Carfilzomib Impurity 17

Ref: 4Z-C-121020

Palbociclib Impurity 14

Ref: 4Z-P-196018

Palbociclib Impurity 28

Ref: 4Z-P-196032

Bestatin Impurity 1

Ref: 4Z-B-119004

N-Nitroso Olaparib Impurity 13

Ref: 4Z-O-032078

Carfilzomib Impurity 47

Ref: 4Z-C-121050

Nintedanib N-Glucuronide-2

Ref: 4Z-N-066037

Carfilzomib Impurity 25

Ref: 4Z-C-121028

Enzalutamide Impurity 13

Ref: 4Z-E-068026

Nintedanib Impurity 55

Ref: 4Z-N-066073

Carfilzomib Impurity 24

Ref: 4Z-C-121027

Lenvatinib Impurity 38 Chloride

Ref: 4Z-L-124044

Carfilzomib Impurity 57

Ref: 4Z-C-121060